The city of Boynton Beach, Florida, currently has 2 active clinical trials seeking participants for Rheumatoid Arthritis research studies.
Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA
Recruiting
This study will confirm the ability of Tc 99m tilmanocept imaging to predict clinical response in individuals with RA who are beginning anti-TNFα therapy.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/31/2023
Locations: RecioMed Clinical Research Network, Boynton Beach, Florida
Conditions: Rheumatoid Arthritis
A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Rheumatoid Arthritis (RENOIR)
Recruiting
RENOIR Study: This study will evaluate the safety, tolerability, and efficacy of Rosnilimab in subjects with moderate to severe Rheumatoid Arthritis (RA)
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
10/11/2023
Locations: Anaptys Bio Investigative Site 10-118, Boynton Beach, Florida
Conditions: Rheumatoid Arthritis